Home Loan Servicing Solutions, Ltd. Reports EPS of $0.76

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Home Loan Servicing Solutions, Ltd. Reports EPS of $0.76 and Net Income of $54.1 Million in the Second Quarter of 2014 and Declares Monthly Dividend of $0.16 Per Share

GEORGE TOWN, Grand Cayman, July 17, 2014 (GLOBE NEWSWIRE) -- Home Loan Servicing Solutions, Ltd. ("HLSS", "our", "we" or the "Company") (Nasdaq: HLSS ) today reported net income of $54.1 million, or $0.76 per ordinary share, for the second quarter of 2014. Additionally, the Company's Board of Directors today declared monthly dividends of $0.16 per ordinary share for July, August and September 2014.

Second quarter business performance highlights:

  • Earned $41.4 million, or $0.58 per ordinary share, after adjusting for the increase in the fair value of our MSR assets of $12.7 million, or $0.18 per ordinary share. The increase in the annualized prepayment speed to 10.9 percent reduced earnings by $0.02 per ordinary share relative to first quarter earnings.
  • Issued $400 million of unrated four-year term notes secured by servicing advance receivables at a weighted average fixed interest rate of 2.88%.
  • Acquired re-performing whole loans with an aggregate UPB of $396.9 million from a large bank. The purchase price for these loans was $276.3 million.
  • Borrowed $219.5 million on a new $290.0 million mortgage loan facility to finance the re-performing loan purchase.

Subsequent to the end of the second quarter of 2014:

  • On July 16, 2014, entered into agreements to extend the maturity of our variable funding notes with an aggregate borrowing capacity of $2.1 billion to August 28, 2015.
  • On July 17, 2014, declared monthly dividends of $0.16 per ordinary share for each of the months of July, August and September 2014.

"After adjusting for the revaluation of our MSR assets, earnings were close to the high-end of our expectations as prepayment speeds increased only modestly from the record low last quarter. This increase was due to the predicted recovery in the rate of liquidations on seriously delinquent loans," said President and CEO John Van Vlack. "Earnings stability will benefit from the issuance of four-year fixed rate term notes and from the reinvestment of cash generated in excess of our dividend in the purchase of re-performing loans."

"As an asset class, I expect re-performing loans to provide an attractive risk-adjusted yield based on the Company's experience with modified loans in our existing servicing portfolio," said Chairman William Erbey. "The strategic fit of re-performing loans is enhanced as the income generated from the prepayment of loans purchased at a discount offers a hedge against prepayments in HLSS' existing non-agency MSRs."

For more information on prior releases and SEC Filings, please refer to the "Shareholders" section of our website at www.hlss.com .

HLSS is an internally-managed owner of residential mortgage assets with historically stable valuations and cash flows. HLSS' largest asset is mortgage servicing advances that, along with the related servicing rights, are over-collateralized more than 25 times by the underlying residential real estate. HLSS' objective is to generate stable, recurring fee-based earnings and dividends throughout the economic cycle. For more information, visit www.hlss.com .

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, included in this press release, including, without limitation, statements we make about our business model, dividend, future earnings, financing, market opportunities, asset performance, asset valuation, business strategy and expectations and objectives for our future performance, are forward-looking statements. These forward-looking statements include declarations regarding our management's beliefs and current expectations. All forward-looking statements are subject to certain risks, uncertainties and assumptions. If one or more of these risks or uncertainties materialize, or if underlying assumptions prove incorrect, our actual results, performance or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Important factors that could cause or contribute to such difference include those risks specific to our business detailed within our reports and filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2013, filed with the SEC on February 6, 2014 (the "2013 Form 10-K") and our Quarterly Report on Form 10-Q for the quarter ended June 30, 2014 (the "Q2 Form 10-Q"). You should not place undue reliance on such forward-looking statements, which speak only as of their dates. We undertake no obligation to update or revise forward-looking statements¸ whether as a result of new information, future events or otherwise. You should carefully consider the risk factors described under the heading "Risk Factors" within our 2013 Form 10-K and our Q2 Form 10-Q.

The following table presents our consolidated results of operations in accordance with U.S. GAAP ("GAAP") reconciled to our internally reported financial results. Accordingly, adjustments are made to reflect Servicing fee revenue, Servicing expense and Amortization expense on a gross rather than a net basis.

Our income from operations as presented in our Management Reporting format shown below should be considered in addition to, and not as a substitute for, income from operations determined in accordance with GAAP.

For the three months ended June 30, 2014: Condensed
Consolidated
Results (GAAP)


Adjustments
Management
Reporting
(Non-GAAP)
       
Revenue      
       
Servicing fee revenue  $ —  $ 185,690  $ 185,690
Interest income - notes receivable – Rights to MSRs  89,969  (89,969)  —
Interest income – other  7,790  —  7,790
Related party revenue(1)   773   —   773
Total revenue   98,532   95,721   194,253
       
Operating expenses      
Compensation and benefits  2,031  —  2,031
Servicing expense  —  90,901  90,901
Amortization of MSRs  —  17,535  17,535
Change in fair value of Notes receivable – Rights to MSRs  —  (12,715)  (12,715)
Related party expenses (2)  496  —  496
General and administrative expenses   1,949   —   1,949
Total operating expenses   4,476   95,721   100,197
Income from operations  $ 94,056  $ —  $ 94,056
 
(1) Revenue earned as part of our Professional Services Agreement with Ocwen Financial Corporation (together with its subsidiaries, collectively "Ocwen").
(2) Expenses incurred as part of our Professional Services Agreement and Administrative Services Agreement with Ocwen and Altisource Portfolio Solutions, S.A., respectively.

 

HOME LOAN SERVICING SOLUTIONS, LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars in thousands, except share data)
(UNAUDITED)
 
  Three months Six months
For the periods ended June 30, 2014 2013 2014 2013
Revenue        
Interest income – notes receivable – Rights to MSRs $ 89,969 $ 49,852 $ 171,821 $ 94,422
Interest income – other  7,790  97  10,750  199
Total interest income  97,759  49,949  182,571  94,621
Related party revenue  773  560  1,401  967
Total revenue  98,532  50,509  183,972  95,588
         
Operating expenses        
Compensation and benefits  2,031  1,602  3,765  2,768
Related party expenses  496  226  868  452
General and administrative expenses  1,949  734  4,098  1,379
Total operating expenses  4,476  2,562  8,731  4,599
         
Income from operations  94,056  47,947  175,241  90,989
         
Other expense        
Interest expense  40,001  20,034  77,512  38,276
Other expense  40,001  20,034  77,512  38,276
         
Income before income taxes  54,055  27,913  97,729  52,713
Income tax expense  —  27  —  39
Net income $ 54,055 $ 27,886 $ 97,729 $ 52,674
         
 
Earnings per share
       
Basic   $ 0.76  $ 0.48 $ 1.38  $ 0.92
Diluted $ 0.76  $ 0.48 $ 1.38  $ 0.92
         
Weighted average ordinary shares outstanding        
Basic   71,016,771  57,633,399 71,016,771  57,133,888
Diluted 71,016,771  57,633,399 71,016,771  57,133,888
         
Dividends declared per share $ 0.48 $ 0.42 $ 0.93 $ 0.80

 

HOME LOAN SERVICING SOLUTIONS, LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in thousands, except share data)
(UNAUDITED)
 
June 30, 2014
December 31,
2013
Assets    
Cash and cash equivalents  $ 89,418  $ 87,896
Match funded advances  6,133,758  6,387,781
Notes receivable – Rights to MSRs  629,579  651,060
Loans held for investment  802,091  —
Related party receivables  17,054  70,049
Deferred tax assets  1,024  1,024
Other assets   261,579   130,153
Total assets  $ 7,934,503  $ 7,327,963
     
Liabilities and Equity    
Liabilities    
Match funded liabilities  $ 5,593,927  $ 5,715,622
Other borrowings  1,049,728  343,386
Dividends payable  11,363  10,653
Income taxes payable  600  682
Deferred tax liabilities   578   1,266
Related party payables  2,990  10,732
Other liabilities   11,147   11,884
Total liabilities   6,670,333   6,094,225
       
       
Equity      
Equity – Ordinary shares, $.01 par value; 200,000,000 shares authorized; 71,016,771 and 71,016,771 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively  710  710  
Additional paid-in capital  1,210,121  1,210,057  
Retained earnings  52,488  20,804  
Accumulated other comprehensive income, net of tax   851   2,167  
Total equity   1,264,170   1,233,738  
Total liabilities and equity  $ 7,934,503  $ 7,327,963  

James E. Lauter Senior Vice President & Chief Financial Officer T: +1 345-815-3932 E:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 232

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 290

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 373

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 104

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 38

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 675

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 144

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 607

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 21

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Cassava Sciences Takes Strategic Steps Amid Clinical Developments

Updated Category News Views 241

Cassava Sciences Provides Key Business Update Cassava Sciences, Inc. (NASDAQ: SAVA), a biotechnology company dedicated to developing innovative treatments for central nervous system disorders, has shared an important business update that affects both its operations and strategic direction. Important Study Results and Future Plans Recent data from the Phase 3 RETHINK-ALZ...

Continue Reading
ColdVentures Welcomes Dr. Barrak Alahmad as Strategic Advisor

Updated Category News Views 164

ColdVentures Expands Leadership with Key Appointment ColdVentures, a pioneering medical device company focused on addressing heat-related illnesses, has taken a significant step forward by appointing Dr. Barrak Alahmad as a strategic advisor. Dr. Alahmad, known for his expertise in environmental health and climate change, brings a wealth of knowledge to the role,...

Continue Reading
Season Group Hits Top 15% with EcoVadis Silver Medal

Updated Category News Views 40

Season Group's Silver Medal Moment Well, it's not every day that a company gets a pat on the back for actually doing something good, but that's what you have here with Season Group snagging the EcoVadis Silver Medal. It’s like the Oscars for sustainability, and it puts them in the top 15% of companies assessed globally by these sustainability gurus. That’s a title...

Continue Reading
LSPedia Achieves Notable Recognition in Business Category

Updated Category News Views 144

LSPedia Celebrated for Excellence in Business LSPedia is thrilled to announce its recent inclusion in Inc.'s 2024 Best in Business list, specifically in the Software as a Service category. This prestigious recognition highlights organizations that are industry leaders and stand out for their impactful achievements. A Testament to Industry Leadership In recognizing...

Continue Reading
Bev Colan Appointed as President of Venn Workforce Optimization

Updated Category News Views 216

Venn Workforce Optimization Welcomes New Leadership In an exciting development for Venn Workforce Optimization, Bev Colan has been named the company president. This marks a significant step for the organization, which specializes in locum tenens optimization and workforce solutions technology. Bev Colan: A Proven Leader Bev Colan joins the Venn team with over 20 years of...

Continue Reading